Latest filing published 12 Jan 2016 for CABOT CORP.
Insider track record
No signal scores available.
Henry F. Mccance: trading record in brief
Henry F. Mccance discloses dealings in 2 companies, chiefly Cabot Corp and Praecis Pharmaceuticals Inc. The record holds 12 filings, for trades running from 29 September 2006 to 8 January 2016.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 12 January 2016: a share grant, in Cabot Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Henry F. Mccance
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 497 sharesCommon StockSEC:0001209191-16-090857:0
- 1,738 shares0Common StockSEC:0001209191-15-003941:0
- 1,451 shares0Common StockSEC:0001209191-14-003139:0
- 1,748 shares0Common StockSEC:0001209191-13-003199:0
- 2,212 shares0Common StockSEC:0001209191-12-003835:0
- 1,796 shares0Common StockSEC:0001209191-11-003731:0
- 2,500 shares0Common StockSEC:0001209191-10-002659:0
- 2,500 shares0Common StockSEC:0001209191-09-002801:0
- 2,500 shares0Common StockSEC:0000016040-08-000012:0
- 14,054 shares@ US$5.00Common Stock, par value $.01 per shareSEC:0001033025-07-000006:0
- 2,500 shares0Common StockSEC:0000016040-07-000010:0
- 2,500 shares0Common StockSEC:0000016040-06-000037:0
12 of 12 declarations
